文献速递慢阻肺肺栓塞与肺血管病

COPD合并重度肺动脉高压对生存的影响及诊断方法

Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic Approach.
PubMed 文献 · Chest · 2022-01-31

该回顾性研究纳入142例COPD疑似肺动脉高压患者,评估无创指标预测重度肺动脉高压的价值及对生存的影响。超声心动图估测收缩期肺动脉压≥56 mmHg、NT-proBNP≥650 pg/mL与CT肺动脉/升主动脉直径比≥0.93联合模型预测重度肺动脉高压的阳性和阴性预测值均为94%。重度肺动脉高压与严重气流受限均独立关联生存,二者并存时死亡风险最高。

要点

  • 超声心动图估测肺动脉收缩压≥56 mmHg、NT-proBNP≥650 pg/mL及CT肺动脉/升主动脉直径比≥0.93联合可高精度预测重度肺动脉高压。
  • 气流受限程度与肺动脉高压严重度均独立关联COPD患者生存。
  • GOLD 3-4级气流受限合并重度肺动脉高压者死亡风险最高。

核心结论

  • 在COPD患者中,超声心动图、NT-proBNP和CT肺动脉/升主动脉直径比联合可高敏感性和特异性预测重度肺动脉高压。
  • 重度肺动脉高压与严重气流受限对生存受损的贡献相当。

研究设计与样本

  • 回顾性分析2005至2018年单中心连续142例COPD疑似肺动脉高压并接受右心导管检查的患者。
  • 采用单变量和逐步多变量logistic回归及校正年龄和性别的Cox回归分析临床变量。

主要发现

  • 纳入患者中位FEV1为55.0%预计值(IQR 42.4%-69.4%),平均肺动脉压35 mmHg(IQR 27-43 mmHg)。
  • 联合模型(超声估测收缩期肺动脉压≥56 mmHg、NT-proBNP≥650 pg/mL、CT肺动脉/升主动脉直径比≥0.93)预测重度肺动脉高压的阳性和阴性预测值均为94%。

关键数值与推荐

  • 超声心动图估测收缩期肺动脉压≥56 mmHg、NT-proBNP血浆水平≥650 pg/mL、CT上肺动脉与升主动脉直径比≥0.93。

临床怎么用

  • 对COPD疑似肺动脉高压患者,可联合超声心动图估测肺动脉压、NT-proBNP和CT肺动脉/升主动脉直径比无创预测重度肺动脉高压。
  • 评估COPD患者死亡风险时,应同时考虑气流受限分级和肺动脉高压严重度,二者并存提示预后更差。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Severe pulmonary hypertension (PH) is prognostically highly relevant in patients with COPD. The criteria for severe PH have been defined based on hemodynamic thresholds in right heart catheterization. RESEARCH QUESTION: Can noninvasive clinical tools predict severe PH in patients with COPD? How does the mortality risk change with increasing severity of airflow limitation and pulmonary vascular disease? STUDY DESIGN AND METHODS: We retrospectively analyzed all consecutive patients with COPD with suspected PH undergoing in-depth clinical evaluation, including right heart catheterization, in our PH clinic between 2005 and 2018. Clinical variables potentially indicative of severe PH or death were analyzed using univariate and stepwise multivariate logistic regression and Cox regression analysis adjusted for age and sex. RESULTS: We included 142 patients with median FEV1 of 55.0% predicted (interquartile range [IQR], 42.4%-69.4% predicted) and mean pulmonary arterial pressure of 35 mm Hg (IQR, 27-43 mm Hg). A multivariate model combining echocardiographic systolic pulmonary arterial pressure of ≥ 56 mm Hg, N-terminal pro-brain natriuretic peptide (NT-proBNP) plasma levels of ≥ 650 pg/mL, and pulmonary artery (PA) to ascending aorta (Ao) diameter ratio on chest CT scan of ≥ 0.93 predicted severe PH with high positive and negative predictive values (both 94%). After correction for age and sex, both airflow limitation (P = .002; Global Initiative for Chronic Obstructive Lung Disease [GOLD] stages 1-2 vs stage 3: hazard ratio [HR], 1.56 [95% CI, 0.90-2.71]; GOLD stages 1-2 vs stage 4: HR, 3.45 [95% CI, 1.75-6.79]) and PH severity (P = .012; HR, 1.85 [95% CI, 1.15-2.99]) remained associated independently with survival. The combination of GOLD stages 3 and 4 airflow limitation and severe PH showed the poorest survival (HR for death, 3.26 [95% CI, 1.62-6.57; P = .001] vs GOLD stages 1-2 combined with nonsevere PH). INTERPRETATION: In patients with COPD, the combination of echocardiography, NT-proBNP level, and PA to Ao diameter ratio predicts severe PH with high sensitivity and specificity. The contribution of severe PH and severe airflow limitation to impaired survival is comparable.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Kovacs G, Avian A, Bachmaier G, et al. Severe Pulmonary Hypertension in COPD: Impact on Survival and Diagnostic Approach. Chest. 2022. PMID: 35092746. doi:10.1016/j.chest.2022.01.031

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。